
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
Supplements and Featured Publications
over 30 years ago
Participantsover 30 years ago
Goals and Long-Term Management of Arthritis with NSAIDsover 30 years ago
Defining the Patient at Risk for NSAID Toxicity


